TheraVac Biotech is a biopharmaceutical company specialized in the fields of DNA & mRNA technologies but also Artificial Intelligence as a new strategy of developing & optimizing biological molecules serving both oncological & vaccination purposes.
Our ultimate goal is to develop a new class of medicines namely prophylactic vaccines such as Covid-19 vaccine and therapeutic cancer vaccines that are aimed at killing tumor cells to achieve successful cancer treatment.
Company Details
- Employees
- 3
- Founded
- 2020
- Address
- Rue Eugène Freyssinet, Paris,paris 75013,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- brandnew-ra.com
- Keywords
- Biotech, Immunotherapy, Vaccines, Life Sciences, Artificial Intelligence, Oncology, DNA, mRNA.
- HQ
- Paris, Paris
Theravac Biotech Questions
Theravac Biotech's website is brandnew-ra.com
Theravac Biotech's LinkedIn profile is https://fr.linkedin.com/company/theravac
Theravac Biotech has
3 employees.
View email and phone details for 3
employees at Theravac Biotech.
Theravac Biotech's industry is
Biotechnology Research
Theravac Biotech's top competitors are
Agent,
Stealth Biotech Startup,
The Msi,
Custom Biologics,
Hls Therapeutics Inc.,
Cherry Biotech,
Bwt Pharma & Biotech,
France Biotech,
Pci Pharma Services,
Us Biologic.
Theravac Biotech's categories are Biotechnology Research
Theravac Biotech's founding year is 2020
